Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Pathway network for the Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

Sources:

Reactome
GeneGo (Thomson Reuters)
WikiPathways

Pathways in the Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

#	Name	Source	Genes
1	Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)	Reactome	ACTB ACTL6A ACTL6B ARID1A ARID1B BCL11A BCL11B BCL7A BCL7B BCL7C DPF1 DPF2 DPF3 PHF10 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SS18 SS18L1 (see all 25) (see less)
2	Transcription Ligand-dependent activation of the ESR1/SP pathway	GeneGo (Thomson Reuters)	ACTB ACTL6A ACTL6B ADA ARID1A ARID1B ARNT CAD CARM1 CCND1 CCNE1 CCNE2 CDC25A CEBPB CREBBP E2F1 EGFR EP300 ESR1 FOS HIF1A KAT2B LDLR NCOA1 NCOA3 NFYA POLA1 POLA2 PRIM1 PRIM2 PRLR RARA SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SP1 SP3 TYMS VEGFA (see all 45) (see less)
3	Regulation of MITF-M-dependent genes involved in pigmentation	Reactome	ACTB ACTL6A AKT2 ARID1A ARID1B BCL7A BCL7B BCL7C CREB1 CTNNB1 DCT DPF1 DPF2 DPF3 GPR143 IRF4 LEF1 MAPK14 MITF MLANA MLPH MYO5A MYRIP PMEL RAB27A SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SOX10 SS18 SS18L1 SYTL2 TFAP2A TYR TYRP1 USF1 (see all 42) (see less)
4	ATP-dependent chromatin remodelers	Reactome	ACTB ACTL6A ACTL6B ARID1A ARID1B ARID2 BCL11A BCL11B BCL7A BCL7B BCL7C BICRA BICRAL BRD7 BRD9 DPF1 DPF2 DPF3 PBRM1 PHF10 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SS18 SS18L1 (see all 31) (see less)
5	Tumor suppressor activity of SMARCB1	WikiPathways	ACTL6A ACTL6B ARID1A ARID1B CDK4 CDK6 CDKN2A DPF1 DPF2 DPF3 EED EZH2 GLI1 GLI2 GLI3 GLI4 H3-3A H3-3B PTCH1 RB1 RBBP4 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SMO SUZ12 (see all 31) (see less)
6	SWI/SNF chromatin remodelers	Reactome	ACTB ACTL6A ACTL6B ARID1A ARID1B ARID2 BCL11A BCL11B BCL7A BCL7B BCL7C BICRA BICRAL BRD7 BRD9 DPF1 DPF2 DPF3 PBRM1 PHF10 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SS18 SS18L1 (see all 31) (see less)
7	Development Ligand-dependent activation of the ESR1/AP-1 pathway	GeneGo (Thomson Reuters)	ACTB ACTL6A ACTL6B ARID1A ARID1B CREBBP CTBP1 EP300 ESR1 FOS HDAC1 HDAC4 JUN NCOA1 NCOA2 NRIP1 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 (see all 25) (see less)
8	Formation of the embryonic stem cell BAF (esBAF) complex	Reactome	ACTB ACTL6A ARID1A BCL11A BCL11B BCL7A BCL7B BCL7C DPF2 PHF10 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 SS18 (see all 19) (see less)
9	Formation of the polybromo-BAF (pBAF) complex	Reactome	ACTB ACTL6A ARID2 BCL7A BCL7B BCL7C BRD7 PBRM1 PHF10 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SMARCE1 (see all 18) (see less)
10	Formation of the canonical BAF (cBAF) complex	Reactome	ACTB ACTL6A ARID1A ARID1B BCL7A BCL7B BCL7C DPF1 DPF2 DPF3 SMARCA2 SMARCA4 SMARCB1 SMARCC1 SMARCD1 SMARCE1 SS18 SS18L1 (see all 18) (see less)
11	Formation of the non-canonical BAF (ncBAF) complex	Reactome	ACTB ACTL6A BCL7A BCL7B BCL7C BICRA BICRAL BRD9 SMARCA2 SMARCA4 SMARCC1 SMARCC2 SMARCD1 SMARCD2 SMARCD3 SS18 SS18L1 (see all 17) (see less)
12	GLI proteins bind promoters of Hh responsive genes to promote transcription	Reactome	GLI1 GLI2 GLI3

Gene overlap in member pathways for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	SMARCA4	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 4	Protein Coding	11
2	SMARCC1	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit C1	Protein Coding	11
3	SMARCD1	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit D1	Protein Coding	11
4	ACTL6A	Actin Like 6A	Protein Coding	11
5	ACTB	Actin Beta	Protein Coding	10
6	SMARCB1	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit B1	Protein Coding	10
7	SMARCC2	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit C2	Protein Coding	10
8	SMARCD2	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit D2	Protein Coding	10
9	SMARCD3	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit D3	Protein Coding	10
10	SMARCE1	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit E1	Protein Coding	10
11	SMARCA2	SWI/SNF Related BAF Chromatin Remodeling Complex Subunit ATPase 2	Protein Coding	9
12	ARID1A	AT-Rich Interaction Domain 1A	Protein Coding	9
13	ARID1B	AT-Rich Interaction Domain 1B	Protein Coding	8
14	BCL7A	BAF Chromatin Remodeling Complex Subunit BCL7A	Protein Coding	8
15	BCL7C	BAF Chromatin Remodeling Complex Subunit BCL7C	Protein Coding	8
16	BCL7B	BAF Chromatin Remodeling Complex Subunit BCL7B	Protein Coding	8
17	DPF2	Double PHD Fingers 2	Protein Coding	7
18	SS18	SS18 Subunit Of BAF Chromatin Remodeling Complex	Protein Coding	7
19	SS18L1	SS18L1 Subunit Of BAF Chromatin Remodeling Complex	Protein Coding	6
20	ACTL6B	Actin Like 6B	Protein Coding	6
21	DPF3	Double PHD Fingers 3	Protein Coding	6
22	DPF1	Double PHD Fingers 1	Protein Coding	6
23	PHF10	PHD Finger Protein 10	Protein Coding	5
24	BCL11A	BCL11 Transcription Factor A	Protein Coding	4
25	BCL11B	BCL11 Transcription Factor B	Protein Coding	4
26	ARID2	AT-Rich Interaction Domain 2	Protein Coding	3
27	BICRAL	BICRA Like Chromatin Remodeling Complex Associated Protein	Protein Coding	3
28	BRD7	Bromodomain Containing 7	Protein Coding	3
29	BICRA	BRD4 Interacting Chromatin Remodeling Complex Associated Protein	Protein Coding	3
30	PBRM1	Polybromo 1	Protein Coding	3
31	BRD9	Bromodomain Containing 9	Protein Coding	3
32	CREBBP	CREB Binding Lysine Acetyltransferase	Protein Coding	2
33	EP300	EP300 Lysine Acetyltransferase	Protein Coding	2
34	ESR1	Estrogen Receptor 1	Protein Coding	2
35	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	2
36	NCOA1	Nuclear Receptor Coactivator 1	Protein Coding	2
37	GLI3	GLI Family Zinc Finger 3	Protein Coding	2
38	GLI2	GLI Family Zinc Finger 2	Protein Coding	2
39	GLI1	GLI Family Zinc Finger 1	Protein Coding	2
40	ADA	Adenosine Deaminase	Protein Coding	1
41	ARNT	Aryl Hydrocarbon Receptor Nuclear Translocator	Protein Coding	1
42	CCND1	Cyclin D1	Protein Coding	1
43	CAD	Carbamoyl-Phosphate Synthetase 2, Aspartate Transcarbamylase, And Dihydroorotase	Protein Coding	1
44	CCNE1	Cyclin E1	Protein Coding	1
45	CDC25A	Cell Division Cycle 25A	Protein Coding	1
46	CEBPB	CCAAT Enhancer Binding Protein Beta	Protein Coding	1
47	E2F1	E2F Transcription Factor 1	Protein Coding	1
48	EGFR	Epidermal Growth Factor Receptor	Protein Coding	1
49	HIF1A	Hypoxia Inducible Factor 1 Subunit Alpha	Protein Coding	1
50	LDLR	Low Density Lipoprotein Receptor	Protein Coding	1
51	NFYA	Nuclear Transcription Factor Y Subunit Alpha	Protein Coding	1
52	POLA1	DNA Polymerase Alpha 1, Catalytic Subunit	Protein Coding	1
53	PRIM1	DNA Primase Subunit 1	Protein Coding	1
54	PRIM2	DNA Primase Subunit 2	Protein Coding	1
55	PRLR	Prolactin Receptor	Protein Coding	1
56	RARA	Retinoic Acid Receptor Alpha	Protein Coding	1
57	SP1	Sp1 Transcription Factor	Protein Coding	1
58	SP3	Sp3 Transcription Factor	Protein Coding	1
59	TYMS	Thymidylate Synthetase	Protein Coding	1
60	VEGFA	Vascular Endothelial Growth Factor A	Protein Coding	1
61	NCOA3	Nuclear Receptor Coactivator 3	Protein Coding	1
62	KAT2B	Lysine Acetyltransferase 2B	Protein Coding	1
63	CCNE2	Cyclin E2	Protein Coding	1
64	CARM1	Coactivator Associated Arginine Methyltransferase 1	Protein Coding	1
65	POLA2	DNA Polymerase Alpha 2, Accessory Subunit	Protein Coding	1
66	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	1
67	MAPK14	Mitogen-Activated Protein Kinase 14	Protein Coding	1
68	CTNNB1	Catenin Beta 1	Protein Coding	1
69	DCT	Dopachrome Tautomerase	Protein Coding	1
70	AKT2	AKT Serine/Threonine Kinase 2	Protein Coding	1
71	MLANA	Melan-A	Protein Coding	1
72	MYRIP	Myosin VIIA And Rab Interacting Protein	Protein Coding	1
73	IRF4	Interferon Regulatory Factor 4	Protein Coding	1
74	MITF	Melanocyte Inducing Transcription Factor	Protein Coding	1
75	MYO5A	Myosin VA	Protein Coding	1
76	GPR143	G Protein-Coupled Receptor 143	Protein Coding	1
77	LEF1	Lymphoid Enhancer Binding Factor 1	Protein Coding	1
78	SYTL2	Synaptotagmin Like 2	Protein Coding	1
79	RAB27A	RAB27A, Member RAS Oncogene Family	Protein Coding	1
80	PMEL	Premelanosome Protein	Protein Coding	1
81	SOX10	SRY-Box Transcription Factor 10	Protein Coding	1
82	TFAP2A	Transcription Factor AP-2 Alpha	Protein Coding	1
83	TYR	Tyrosinase	Protein Coding	1
84	TYRP1	Tyrosinase Related Protein 1	Protein Coding	1
85	USF1	Upstream Transcription Factor 1	Protein Coding	1
86	MLPH	Melanophilin	Protein Coding	1
87	EED	Embryonic Ectoderm Development	Protein Coding	1
88	SMO	Smoothened, Frizzled Class Receptor	Protein Coding	1
89	RB1	RB Transcriptional Corepressor 1	Protein Coding	1
90	PTCH1	Patched 1	Protein Coding	1
91	H3-3B	H3.3 Histone B	Protein Coding	1
92	H3-3A	H3.3 Histone A	Protein Coding	1
93	SUZ12	SUZ12 Polycomb Repressive Complex 2 Subunit	Protein Coding	1
94	EZH2	Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit	Protein Coding	1
95	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	1
96	CDK6	Cyclin Dependent Kinase 6	Protein Coding	1
97	CDK4	Cyclin Dependent Kinase 4	Protein Coding	1
98	RBBP4	RB Binding Protein 4, Chromatin Remodeling Factor	Protein Coding	1
99	GLI4	GLI Family Zinc Finger 4	Protein Coding	1
100	CTBP1	C-Terminal Binding Protein 1	Protein Coding	1
101	HDAC1	Histone Deacetylase 1	Protein Coding	1
102	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
103	NRIP1	Nuclear Receptor Interacting Protein 1	Protein Coding	1
104	HDAC4	Histone Deacetylase 4	Protein Coding	1
105	NCOA2	Nuclear Receptor Coactivator 2	Protein Coding	1

Disorders associated with Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Coffin-siris syndrome 1	Enrichment	ARID1A, ARID1B, DPF2, SMARCA4, SMARCB1, SMARCD1, SMARCE1	11.06
2	Inherited cancer-predisposing syndrome	Enrichment	CDK4, CDKN2A, EZH2, PTCH1, RB1, SMARCA4, SMARCB1, SMARCE1	9.37
3	Albinism	Enrichment	DCT, GPR143, TYR, TYRP1	8.92
4	Postaxial polydactyly type b	Enrichment	GLI1, GLI3	7.49
5	Albinism, ocular, type i	Enrichment	GPR143, TYR, TYRP1	6.26
6	Waardenburg syndrome, type 2e	Enrichment	MITF, SOX10, TYR	6.02
7	Rhabdoid tumor predisposition syndrome	Enrichment	SMARCA4, SMARCB1	5.78
8	Meningioma	Enrichment	SMARCB1, SMARCE1, SMO	5.63
9	Rare genetic intellectual disability	Enrichment	ARID1B, CREBBP, EP300	5.61
10	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	Enrichment	ARID1A, ARID1B, BCL11A	5.52
11	Polydactyly, postaxial, type a1	Enrichment	GLI1, GLI3	5.47
12	Bryant-li-bhoj neurodevelopmental syndrome 2	Enrichment	H3-3A, H3-3B	5.30
13	Craniosynostosis	Enrichment	GLI2, GLI3	5.21
14	Griscelli syndrome, type 3	Enrichment	MLPH, MYO5A	5.03
15	Melanoma, cutaneous malignant 8	Enrichment	MITF, TYR	5.03
16	Nicolaides-baraitser syndrome	Enrichment	ARID1B, SMARCA2	5.00
17	Blepharophimosis	Enrichment	ARID1B, SMARCA2	5.00
18	Smarca2-related nicolaides-baraitser syndrome	Enrichment	ARID1B, SMARCA2	5.00
19	Weaver syndrome	Enrichment	EZH2, SUZ12	4.82
20	Umbilical hernia	Enrichment	ACTL6A, GLI3	4.82
21	Waardenburg syndrome, type 2a	Enrichment	MITF, SOX10	4.55
22	Bladder cancer	Enrichment	ARID1A, CDKN2A, RB1	4.42
23	Autism spectrum disorder	Enrichment	ACTL6B, ARID1B, BCL11B, SMARCB1	4.36
24	Rubinstein-taybi syndrome 1	Enrichment	CREBBP, EP300	4.31
25	Chromosome 16p13.3 deletion syndrome, proximal	Enrichment	CREBBP, EP300	4.31
26	Hypertrichosis	Enrichment	ARID1B, CREBBP	4.31
27	Microcephaly	Enrichment	ACTB, ARID1A, ARID1B, BCL11B	4.15
28	Ovarian cancer	Enrichment	CDKN2A, PTCH1, RB1, SMARCB1	4.11
29	Atrial heart septal defect	Enrichment	ACTL6A, SMARCA4	4.09
30	Interatrial communication	Enrichment	ACTL6A, SMARCA4	4.09
31	Meningioma, familial	Enrichment	SMARCB1, SMARCE1	4.04
32	Congenital hydrocephalus	Enrichment	PTCH1, SMARCC1	3.98
33	Waardenburg syndrome, type 4a	Enrichment	MITF, SOX10	3.86
34	Waardenburg syndrome	Enrichment	MITF, SOX10	3.86
35	Cowden syndrome 1	Enrichment	EGFR, LDLR	3.80
36	Waardenburg syndrome, type 1	Enrichment	MITF, SOX10	3.71
37	Oculocutaneous albinism	Enrichment	TYR, TYRP1	3.71
38	Pallister-hall syndrome	Enrichment	GLI3	3.66
39	Greig cephalopolysyndactyly syndrome	Enrichment	GLI3	3.66
40	Polydactyly, preaxial iv	Enrichment	GLI3	3.66
41	Polydactyly, preaxial i	Enrichment	GLI1	3.66
42	Culler-jones syndrome	Enrichment	GLI2	3.66
43	Polydactyly, postaxial, type a8	Enrichment	GLI1	3.66
44	Holoprosencephaly 9	Enrichment	GLI2	3.66
45	Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome	Enrichment	GLI2	3.66
46	Lip and oral cavity carcinoma	Enrichment	CDKN2A, RB1	3.48
47	Corpus callosum, agenesis of	Enrichment	ARID1B, BCL11A	3.47
48	Isolated corpus callosum agenesis	Enrichment	ARID1B, BCL11A	3.47
49	Intellectual disability-hypoplastic corpus callosum-preauricular tag syndrome	Enrichment	ARID1B, BCL11A	3.47
50	White-sutton syndrome	Enrichment	GLI2	3.35
51	Tibial hemimelia	Enrichment	GLI3	3.35
52	Synpolydactyly	Enrichment	GLI3	3.35
53	Septopreoptic holoprosencephaly	Enrichment	GLI2, PTCH1	3.28
54	Midline interhemispheric variant of holoprosencephaly	Enrichment	GLI2, PTCH1	3.28
55	Microform holoprosencephaly	Enrichment	GLI2, PTCH1	3.23
56	Lobar holoprosencephaly	Enrichment	GLI2, PTCH1	3.23
57	Acrocallosal syndrome	Enrichment	GLI3	3.18
58	Aarskog-scott syndrome	Enrichment	GLI3	3.18
59	Melanoma, cutaneous malignant 1	Enrichment	CDK4, CDKN2A	3.17
60	Alobar holoprosencephaly	Enrichment	GLI2, PTCH1	3.17
61	Semilobar holoprosencephaly	Enrichment	GLI2, PTCH1	3.12
62	Hypercholesterolemia, familial, 1	Enrichment	LDLR, SMARCA4	3.09
63	Familial hypercholesterolemia	Enrichment	LDLR, SMARCA4	2.96
64	Torticollis	Enrichment	ACTL6A	2.90
65	Baraitser-winter syndrome 1	Enrichment	ACTB	2.90
66	Coffin-siris syndrome 11	Enrichment	SMARCD1	2.90
67	Hydrocephalus, congenital, 5	Enrichment	SMARCC1	2.90
68	Congenital smooth muscle hamartoma, with or without hemihypertrophy	Enrichment	ACTB	2.90
69	Becker nevus syndrome	Enrichment	ACTB	2.90
70	Dystonia-deafness syndrome 1	Enrichment	ACTB	2.90
71	Smarca4-deficient sarcoma of thorax	Enrichment	SMARCA4	2.90
72	Ovarian small cell carcinoma	Enrichment	SMARCA4	2.90
73	Blepharophimosis-impaired intellectual development syndrome	Enrichment	SMARCA2	2.90
74	Thrombocytopenia 8, with dysmorphic features and developmental delay	Enrichment	ACTB	2.90
75	Baraitser-winter syndrome	Enrichment	ACTB	2.90
76	Autosomal recessive severe congenital neutropenia	Enrichment	SMARCD2	2.90
77	Congenital smooth muscle hamartoma	Enrichment	ACTB	2.90
78	Developmental malformations-deafness-dystonia syndrome	Enrichment	ACTB	2.90
79	Coffin-siris syndrome 5	Enrichment	SMARCE1	2.88
80	Rhabdoid tumor predisposition syndrome 1	Enrichment	SMARCB1	2.88
81	Neurilemmoma	Enrichment	SMARCB1	2.88
82	Coffin-siris syndrome 3	Enrichment	SMARCB1	2.88
83	Facial cleft	Enrichment	SMARCE1	2.88
84	Arid1b-related disorder	Enrichment	ARID1B	2.88
85	Coffin-siris syndrome 7	Enrichment	DPF2	2.88
86	Fetal hemoglobin quantitative trait locus 5	Enrichment	BCL11A	2.85
87	Immunodeficiency 49, severe combined	Enrichment	BCL11B	2.85
88	Intellectual developmental disorder with speech delay, dysmorphic facies, and t-cell abnormalities	Enrichment	BCL11B	2.85
89	Intellectual developmental disorder with persistence of fetal hemoglobin	Enrichment	BCL11A	2.85
90	Bcl11a-related intellectual disability	Enrichment	BCL11A	2.85
91	Combined pituitary hormone deficiency	Enrichment	GLI2	2.75
92	Intellectual developmental disorder with severe speech and ambulation defects	Enrichment	ACTL6B	2.73
93	Chromosome 2q37 deletion syndrome	Enrichment	HDAC4	2.73
94	Congenital anomalies of kidney and urinary tract 3	Enrichment	NRIP1	2.73
95	Menke-hennekam syndrome 1	Enrichment	CREBBP	2.73
96	Neurodevelopmental disorder with central hypotonia and dysmorphic facies	Enrichment	HDAC4	2.73
97	Rubinstein-taybi syndrome due to 16p13.3 microdeletion	Enrichment	CREBBP	2.73
98	Menke-hennekam syndrome	Enrichment	CREBBP	2.73
99	Hirschsprung disease 1	Enrichment	GLI3, SMO	2.70
100	Ellis-van creveld syndrome	Enrichment	GLI1	2.70
101	Curry-jones syndrome	Enrichment	SMO	2.64
102	Melanoma, cutaneous malignant 3	Enrichment	CDK4	2.64
103	Schilbach-rott syndrome	Enrichment	PTCH1	2.64
104	Microcephaly 12, primary, autosomal recessive	Enrichment	CDK6	2.64
105	Imagawa-matsumoto syndrome	Enrichment	SUZ12	2.64
106	Cohen-gibson syndrome	Enrichment	EED	2.64
107	Bryant-li-bhoj neurodevelopmental syndrome 1	Enrichment	H3-3A	2.64
108	Trilateral retinoblastoma	Enrichment	RB1	2.64
109	Cdkn2a cancer predisposition	Enrichment	CDKN2A	2.64
110	Turner syndrome	Enrichment	PTCH1	2.64
111	Monosomy 9q22.3	Enrichment	PTCH1	2.64
112	Lung oat cell carcinoma	Enrichment	RB1	2.64
113	Alopecia, androgenetic, 1	Enrichment	SMARCD1	2.60
114	Specific granule deficiency 1	Enrichment	SMARCD2	2.60
115	Rhabdoid tumor predisposition syndrome 2	Enrichment	SMARCA4	2.60
116	Specific granule deficiency 2	Enrichment	SMARCD2	2.60
117	Coffin-siris syndrome 8	Enrichment	SMARCC2	2.60
118	Otosclerosis 12	Enrichment	SMARCA4	2.60
119	Coffin-siris syndrome 4	Enrichment	SMARCA4	2.60
120	Baraitser-winter cerebrofrontofacial syndrome	Enrichment	ACTB	2.60
121	Blepharophimosis - intellectual disability syndrome	Enrichment	SMARCA2	2.60
122	Coffin-siris syndrome 12	Enrichment	BICRA	2.60
123	Specific granule deficiency	Enrichment	SMARCD2	2.60
124	Schwannomatosis 1	Enrichment	SMARCB1	2.58
125	Coffin-siris syndrome 6	Enrichment	ARID2	2.58
126	Malignant granular cell myoblastoma	Enrichment	BRD7	2.58
127	Granular cell carcinoma	Enrichment	BRD7	2.58
128	Trichomegaly	Enrichment	ARID1B	2.58
129	Chromosome 6q24-q25 deletion syndrome	Enrichment	ARID1B	2.58
130	Severe combined immunodeficiency with sensitivity to ionizing radiation	Enrichment	ARID1B	2.58
131	Diaphragmatic hernia, congenital	Enrichment	GLI3	2.54
132	Colorectal cancer	Enrichment	ARID1A, CCND1, EP300	2.53
133	Hypoinsulinemic hypoglycemia with hemihypertrophy	Enrichment	AKT2	2.51
134	Nystagmus 6, congenital, x-linked	Enrichment	GPR143	2.51
135	Griscelli syndrome, type 2	Enrichment	RAB27A	2.51
136	Hyperlipidemia, familial combined, 1	Enrichment	USF1	2.51
137	Albinism, oculocutaneous, type ib	Enrichment	TYR	2.51
138	Skin/hair/eye pigmentation, variation in, 8	Enrichment	IRF4	2.51
139	Heterochromia iridis	Enrichment	MITF	2.51
140	Tietz albinism-deafness syndrome	Enrichment	MITF	2.51
141	Griscelli syndrome, type 1	Enrichment	MYO5A	2.51
142	Elejalde neuroectodermal melanolysosomal syndrome	Enrichment	MYO5A	2.51
143	Ectodermal dysplasia 17 with or without limb malformations	Enrichment	LEF1	2.51
144	Skin/hair/eye pigmentation, variation in, 3	Enrichment	TYR	2.51
145	Immunodeficiency 131	Enrichment	IRF4	2.51
146	Coloboma, osteopetrosis, microphthalmia, macrocephaly, albinism, and deafness	Enrichment	MITF	2.51
147	Griscelli syndrome	Enrichment	RAB27A	2.51
148	Adenoid ameloblastoma	Enrichment	CTNNB1	2.51
149	Minimal pigment oculocutaneous albinism type 1	Enrichment	TYR	2.51
150	Whipple disease	Enrichment	IRF4	2.51
151	Microcystic stromal tumor	Enrichment	CTNNB1	2.51
152	Hypopigmentation of the skin	Enrichment	TYR	2.51
153	Akt2-related familial partial lipodystrophy	Enrichment	AKT2	2.51
154	Van esch-o'driscoll syndrome	Enrichment	POLA1	2.48
155	Multiple fibroadenomas of the breast	Enrichment	PRLR	2.48
156	Pigmentary disorder, reticulate, with systemic manifestations, x-linked	Enrichment	POLA1	2.48
157	Hyperprolactinemia	Enrichment	PRLR	2.48
158	Microvascular complications of diabetes 1	Enrichment	VEGFA	2.48
159	Familial hyperprolactinemia	Enrichment	PRLR	2.48
160	Developmental and epileptic encephalopathy 76	Enrichment	ACTL6B	2.43
161	Thumb deformity	Enrichment	CREBBP	2.43
162	Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome	Enrichment	CTBP1	2.43
163	Menke-hennekam syndrome 2	Enrichment	EP300	2.43
164	Acute myeloid leukemia with kat6a-crebbp fusion	Enrichment	CREBBP	2.43
165	Sarcoma, synovial	Enrichment	SS18	2.43
166	Atypical teratoid rhabdoid tumor	Enrichment	SMARCB1	2.40
167	Desmoplastic/nodular medulloblastoma	Enrichment	ARID2	2.40
168	Schwannomatosis	Enrichment	SMARCB1	2.40
169	Nail disorder, nonsyndromic congenital, 9	Enrichment	ARID1B	2.40
170	Coffin-siris syndrome 2	Enrichment	ARID1A	2.40
171	Periventricular leukomalacia	Enrichment	ARID1A	2.40
172	Gastric cancer	Enrichment	CDK4, CDKN2A	2.37
173	Melanoma-astrocytoma syndrome	Enrichment	CDKN2A	2.34
174	Pallister-hall-like syndrome	Enrichment	SMO	2.34
175	Melanoma, cutaneous malignant 2	Enrichment	CDKN2A	2.34
176	Chromosome 13q14 deletion syndrome	Enrichment	RB1	2.34
177	Melanoma-pancreatic cancer syndrome	Enrichment	CDKN2A	2.34
178	Familial retinoblastoma	Enrichment	RB1	2.34
179	Myeloma, multiple	Enrichment	CREBBP, HDAC4	2.33
180	Aminoacylase 1 deficiency	Enrichment	ACTB	2.30
181	Pseudomyogenic hemangioendothelioma	Enrichment	ACTB	2.30
182	Full schwannomatosis	Enrichment	SMARCB1	2.28
183	Clear cell papillary renal cell carcinoma	Enrichment	PBRM1	2.28
184	Estrogen resistance	Enrichment	ESR1	2.26
185	Tethered spinal cord syndrome	Enrichment	CREBBP	2.26
186	Intraocular pressure quantitative trait locus	Enrichment	CREBBP	2.26
187	Migraine without aura	Enrichment	ESR1	2.26
188	Ectrodactyly and ectodermal dysplasia without cleft lip/palate	Enrichment	LEF1	2.21
189	Albinism, oculocutaneous, type iii	Enrichment	TYRP1	2.21
190	Osteopathia striata with cranial sclerosis	Enrichment	CTNNB1	2.21
191	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	2.21
192	Waardenburg syndrome, type 4c	Enrichment	SOX10	2.21
193	Albinism, oculocutaneous, type ia	Enrichment	TYR	2.21
194	Skin/hair/eye pigmentation, variation in, 11	Enrichment	TYRP1	2.21
195	Oculocutaneous albinism, type viii	Enrichment	DCT	2.21
196	Childhood hepatocellular carcinoma	Enrichment	CTNNB1	2.21
197	Split hand-foot malformation	Enrichment	LEF1	2.21
198	Papillary renal cell carcinoma	Enrichment	MITF	2.21
199	Peripheral demyelinating neuropathy, central dysmyelination, waardenburg syndrome, and hirschsprung disease	Enrichment	SOX10	2.21
200	Esotropia	Enrichment	TFAP2A	2.21
201	Juvenile nasopharyngeal angiofibroma	Enrichment	CTNNB1	2.21
202	Teratoma	Enrichment	CTNNB1	2.21
203	Lens subluxation	Enrichment	TFAP2A	2.21
204	Developmental and epileptic encephalopathy 50	Enrichment	CAD	2.18
205	Hyperlipoproteinemia, type iii	Enrichment	LDLR	2.18
206	Primordial dwarfism-immunodeficiency-lipodystrophy syndrome	Enrichment	PRIM1	2.18
207	Dyskeratosis congenita, digenic	Enrichment	TYMS	2.18
208	Retinoblastoma	Enrichment	RB1	2.16
209	Osteogenic sarcoma	Enrichment	RB1	2.16
210	Holoprosencephaly 7	Enrichment	PTCH1	2.16
211	Woolly hair, autosomal recessive 3	Enrichment	RB1	2.16
212	Hypotrichosis 8	Enrichment	RB1	2.16
213	Dedifferentiated liposarcoma	Enrichment	CDK4	2.16
214	Squamous cell carcinoma	Enrichment	RB1	2.16
215	Bone osteosarcoma	Enrichment	RB1	2.16
216	Well-differentiated liposarcoma	Enrichment	CDK4	2.16
217	Hereditary persistence of fetal hemoglobin-sickle cell disease syndrome	Enrichment	BCL11A	2.16
218	Lipodystrophy, congenital generalized, type 2	Enrichment	ACTL6B	2.13
219	Congenital generalized lipodystrophy	Enrichment	FOS	2.13
220	Arthrogryposis multiplex congenita 3, myogenic type	Enrichment	ESR1	2.13
221	Inguinal hernia	Enrichment	ACTL6A	2.13
222	Autism	Enrichment	ACTL6B, CREBBP	2.11
223	Clear cell renal cell carcinoma	Enrichment	PBRM1	2.10
224	Wiedemann-steiner syndrome	Enrichment	ARID1B	2.10
225	Breast cancer	Enrichment	ESR1, JUN	2.08
226	Polydactyly, preaxial ii	Enrichment	PTCH1	2.04
227	Small cell cancer of the lung	Enrichment	RB1	2.04
228	Lynch syndrome 4	Enrichment	RB1	2.04
229	Rubinstein-taybi syndrome 2	Enrichment	EP300	2.04
230	Histiocytoid hemangioma	Enrichment	FOS	2.04
231	Desmoid disease, hereditary	Enrichment	CTNNB1	2.03
232	Neurodevelopmental disorder with spastic diplegia and visual defects	Enrichment	CTNNB1	2.03
233	Anus, imperforate	Enrichment	CTNNB1	2.03
234	Exudative vitreoretinopathy 7	Enrichment	CTNNB1	2.03
235	Desmoid tumor	Enrichment	CTNNB1	2.03
236	Melanoma of soft tissue	Enrichment	CREB1	2.03
237	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency	Enrichment	ADA	2.00
238	Hypercholesterolemia, familial, 2	Enrichment	LDLR	2.00
239	Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia	Enrichment	LDLR	2.00
240	Partington syndrome	Enrichment	POLA1	2.00
241	Hypercholesterolemia, familial, 4	Enrichment	LDLR	2.00
242	Neonatal nephrocutaneous inflammatory syndrome	Enrichment	EGFR	2.00
243	Syndromic x-linked intellectual disability najm type	Enrichment	LDLR	2.00
244	Neonatal inflammatory skin and bowel disease	Enrichment	EGFR	2.00
245	Enchondromatosis	Enrichment	HIF1A	2.00
246	Gastroesophageal reflux	Enrichment	ACTL6A	2.00
247	Neuroblastoma	Enrichment	SMARCA4	2.00
248	Wolf-hirschhorn syndrome	Enrichment	CTBP1	1.96
249	Ventricular septal defect	Enrichment	SMARCA4	1.95
250	Endometrial stromal sarcoma	Enrichment	SUZ12	1.94
251	Branchiooculofacial syndrome	Enrichment	TFAP2A	1.91
252	Pilomatrixoma	Enrichment	CTNNB1	1.91
253	Alazami syndrome	Enrichment	CTNNB1	1.91
254	Craniopharyngioma	Enrichment	CTNNB1	1.91
255	Male infertility with azoospermia or oligozoospermia due to single gene mutation	Enrichment	GLI2	1.91
256	Mantle cell lymphoma	Enrichment	CCND1	1.88
257	Adenosine deaminase deficiency	Enrichment	ADA	1.88
258	Li-fraumeni syndrome	Enrichment	CDKN2A	1.87
259	Basal cell nevus syndrome 1	Enrichment	PTCH1	1.87
260	Basal cell carcinoma 1	Enrichment	PTCH1	1.87
261	Adrenocortical carcinoma	Enrichment	CDKN2A	1.87
262	Lung squamous cell carcinoma	Enrichment	CDKN2A	1.87
263	Combined immunodeficiency	Enrichment	BCL11B	1.82
264	Combined t cell and b cell immunodeficiency	Enrichment	BCL11B	1.82
265	Combined t and b cell immunodeficiency	Enrichment	BCL11B	1.82
266	Hyperlipidemia, familial combined, 3	Enrichment	USF1	1.81
267	Exudative vitreoretinopathy 1	Enrichment	CTNNB1	1.81
268	Albinism, oculocutaneous, type ii	Enrichment	TYRP1	1.81
269	Hypogonadotropic hypogonadism 1 with or without anosmia	Enrichment	SOX10	1.81
270	Amblyopia	Enrichment	TFAP2A	1.81
271	Septooptic dysplasia	Enrichment	ARID1A	1.80
272	Overgrowth syndrome	Enrichment	PTCH1	1.80
273	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	CDKN2A	1.80
274	Charge syndrome	Enrichment	EP300	1.78
275	Enchondromatosis, multiple, ollier type	Enrichment	HIF1A	1.78
276	Von hippel-lindau syndrome	Enrichment	CCND1	1.78
277	Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative	Enrichment	ADA	1.78
278	Nk-cell enteropathy	Enrichment	SMARCB1	1.77
279	Pituitary stalk interruption syndrome	Enrichment	SMARCA2	1.76
280	Glioma susceptibility 1	Enrichment	H3-3A	1.74
281	Branchiootorenal syndrome 1	Enrichment	TFAP2A	1.73
282	Weyers acrofacial dysostosis	Enrichment	CTNNB1	1.73
283	Split-hand/foot malformation 1	Enrichment	LEF1	1.73
284	Renal cell carcinoma, nonpapillary	Enrichment	PBRM1	1.70
285	Lipid metabolism disorder	Enrichment	LDLR	1.70
286	Migraine with or without aura 1	Enrichment	ESR1	1.70
287	Cleft palate, isolated	Enrichment	SMARCA4	1.68
288	Branchiootorenal syndrome	Enrichment	TFAP2A	1.67
289	Gallbladder cancer	Enrichment	CTNNB1	1.67
290	Complex neurodevelopmental disorder	Enrichment	ACTL6A, ACTL6B	1.66
291	Melanoma	Enrichment	CDKN2A	1.65
292	Squamous cell carcinoma, head and neck	Enrichment	EGFR	1.64
293	Multiple enchondromatosis, maffucci type	Enrichment	HIF1A	1.64
294	Exudative vitreoretinopathy	Enrichment	CTNNB1	1.61
295	Rare genetic deafness	Enrichment	MITF, SOX10	1.61
296	Leukemia, acute lymphoblastic	Enrichment	CDKN2A	1.60
297	Heart disease	Enrichment	CREBBP	1.59
298	Homozygous familial hypercholesterolemia	Enrichment	LDLR	1.58
299	Adult hepatocellular carcinoma	Enrichment	CTNNB1	1.56
300	Coronary heart disease 5	Enrichment	LDLR	1.53
301	Cat eye syndrome	Enrichment	TFAP2A	1.52
302	Optic nerve disease	Enrichment	TYR	1.52
303	Medulloblastoma	Enrichment	PTCH1	1.50
304	Lung cancer susceptibility 3	Enrichment	RB1	1.50
305	Leukemia, chronic lymphocytic	Enrichment	CCND1	1.49
306	Omenn syndrome	Enrichment	ADA	1.49
307	Hydrops fetalis, nonimmune	Enrichment	ARID1A	1.47
308	Diffuse large b-cell lymphoma	Enrichment	CREBBP	1.46
309	Lung non-small cell carcinoma	Enrichment	EGFR	1.44
310	Rhabdomyosarcoma	Enrichment	PTCH1	1.44
311	Epicanthus	Enrichment	TFAP2A	1.44
312	Myocardial infarction	Enrichment	ESR1	1.40
313	Non-immune hydrops fetalis	Enrichment	ARID1A	1.39
314	Acute promyelocytic leukemia	Enrichment	RARA	1.37
315	Scoliosis	Enrichment	CREBBP	1.36
316	Macs syndrome	Enrichment	PTCH1	1.35
317	Myopia	Enrichment	TYR	1.34
318	Seckel syndrome	Enrichment	PRIM1	1.34
319	Cerebral palsy	Enrichment	SMARCA4	1.32
320	Microphthalmia	Enrichment	PTCH1	1.31
321	Precursor t-cell acute lymphoblastic leukemia	Enrichment	CDKN2A	1.29
322	Polycystic liver disease	Enrichment	CTNNB1	1.29
323	Autosomal dominant polycystic liver disease	Enrichment	CTNNB1	1.29
324	Gliosarcoma	Enrichment	EGFR	1.29
325	Giant cell glioblastoma	Enrichment	EGFR	1.26
326	Pancreatic cancer	Enrichment	CDKN2A	1.25
327	Cakut	Enrichment	NRIP1	1.22
328	Arteriovenous malformations of the brain	Enrichment	EGFR	1.21
329	Dyskeratosis congenita	Enrichment	TYMS	1.21
330	Hepatoblastoma	Enrichment	CTNNB1	1.20
331	Hepatocellular carcinoma	Enrichment	CTNNB1	1.18
332	Multisystem inflammatory syndrome in children	Enrichment	RAB27A	1.18
333	Skin disease	Enrichment	TYR	1.18
334	Kallmann syndrome	Enrichment	SOX10	1.16
335	Primary autosomal recessive microcephaly	Enrichment	CDK6	1.15
336	Ear malformation	Enrichment	MITF	1.14
337	Autoinflammatory disease	Enrichment	RAB27A	1.14
338	Hereditary breast carcinoma	Enrichment	ESR1	1.11
339	Developmental and epileptic encephalopathy 1	Enrichment	CAD	1.10
340	Strabismus	Enrichment	TYR	1.09
341	Undetermined early-onset epileptic encephalopathy	Enrichment	ACTL6B	1.01
342	Lung cancer	Enrichment	EGFR	1.00
343	Dystonia	Enrichment	MYO5A	0.99
344	Eye disease	Enrichment	TYR	0.99
345	Severe combined immunodeficiency	Enrichment	ADA	0.98
346	Non-syndromic genetic deafness	Enrichment	MITF	0.98
347	Hereditary breast ovarian cancer syndrome	Enrichment	PTCH1	0.93
348	Type 2 diabetes mellitus	Enrichment	AKT2	0.91
349	Nonsyndromic hearing loss	Enrichment	MITF	0.91
350	Hypertelorism	Enrichment	TFAP2A	0.83
351	Rare autosomal dominant non-syndromic sensorineural deafness type dfna	Enrichment	MITF	0.83
352	Congenital nervous system abnormality	Enrichment	CREBBP	0.75
353	Nervous system disease	Enrichment	CREBBP	0.75
354	Primary ovarian insufficiency	Enrichment	PRLR	0.75

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Pathway Network for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Pathway network for the Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

Member Pathways for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Pathways in the Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

Gene overlap in member pathways for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

Associated Genes for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Associated Disorders for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Disorders associated with Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) SuperPath

STRING Interaction Network for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)

Sources for Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF)